Elicera Therapeutics (ELIC)

Last close As at 04/02/2025

0.00 (0.00%)

Market capitalisation

Elicera Therapeutics is a Sweden-based clinical-stage cell and gene therapy company focussed on developing next generation immuno-oncology treatments based on iTANK-armed oncolytic viruses and CAR-T cells.

Sector

Healthcare

Equity Analyst

Key Management

  • Jamal El-Mosleh

    CEO and co-founder

  • Ingvar Karlsson

    Chief Financial Officer

Thematics

thematic

Healthcare

Healthcare-focused trusts: A sector on the mend

thematic

Healthcare

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

volition01

thematic

Healthcare

VolitionRx – Decoding the DNA of cancer 

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free